Tranexamic Acid in the Control of Spontaneous Bleeding in Severe Haemophilia

S. G Rainsford; A. J Jouhar; Angela Hall

doi:10.1055/s-0038-1649074

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1973; 30(02): 272-279
DOI: 10.1055/s-0038-1649074

Original Article

Schattauer GmbH

Tranexamic Acid in the Control of Spontaneous Bleeding in Severe Haemophilia

S. G Rainsford

¹Lord Mayor Treloar Hospital, Alton, Hampshire, and Kabi Pharmaceuticals Limited, Ealing, London

,

A. J Jouhar

¹Lord Mayor Treloar Hospital, Alton, Hampshire, and Kabi Pharmaceuticals Limited, Ealing, London

,

Angela Hall

¹Lord Mayor Treloar Hospital, Alton, Hampshire, and Kabi Pharmaceuticals Limited, Ealing, London

› Author Affiliations

Abstract

Summary

A double-blind cross-over study of the prophylactic value of tranexamic acid (“Cyklokapron”), in a dose of 3.0 g per day, against spontaneous bleeding episodes in severe haemophilia was undertaken. Records of bleeding episodes were maintained during therapy in twenty boys with confirmed clinical severity, over two school terms. A significant reduction (p <0.05) in spontaneous bleeding episodes was attained with an associated lessening in the transfusion requirement of therapeutic material, and without obvious side effects. Recommendations are made for further investigations.

Full Text

References

References
1 Bennett A. E, Ingram G. I. C, and Inglish P. J. 1973; Antifibrinolytic Treatment in Haemophilia: A Controlled Trial of Prophylaxis with Tranexamic Acid. British Journal of Haematology 24: 83.
2 Biggs R, Evellng J, and Richards G. 1955; The Assay of Antihaemophilicglobulin Activity. British Journal of Haematology 1: 20.
3 Denson K. W. E, and Biggs R. 1972. Laboratory diagnosis tests of clotting function and their standardisation. In: Biggs R. (ed.) Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford: 288.
4 Dubber A. H. C, MeNicol G. P, and Douglas A. S. 1965; Amino Methyl Cyclohexane Carboxylic Acid. A New Synthetic Fibrinolytic Inhibitor. British Journal of Haematology 11: 237.
5 Forbes C. D, Barr R. D, Reid G, Thomson C, Prentice C. R. M, McNicol G. P, and Douglas A. S. 1972; Tranexamic Acid in Control of Haemorrhage after Dental Extraction in Haemophilia and Christmas Disease. British Medical Journal 2: 311.
6 Gordon A. M, McNicol G. P, Dubber A. H. C, McDonald G. A, and Douglas A. S. 1965; Clinical Trial of Epsilon - Aminocaproic Acid in Severe Haemophilia. British Medical Journal 1: 1632.
7 Lee R. I, and White P. D. 1913; A Clinical Study of the Coagulation time of Blood. American Journal of the Medical Sciences 145: 495.
8 Mainwaring D, and Keidan S. E. 1965; The Effect of Epsilon-Aminocaproio Acid. British Journal of Haematology 11: 682.
9 Matsuoka M, and Nomura J. 1967; The Actions and Clinical Effects of E. A. C. A. and Tamoha (Tranexamic Acid). Shinryo 20: 89.
10 McNicol G. P, Fletcher A. S, Alkjaersig N, and Sherry S. 1961; The Use of Epsilon Aminocaproic Acid, a potent Inhibitor of Fibrinolytic Activity in the Management of Postoperative Haematuria. The Journal of Urology (Baltimore) 86: 829.
11 Nilsson I. M, Andersson L, and Bjorkman S. E. 1969 Epsilon Aminocaproic Acid as a Therapeutic Agent. Acta Medica Scandinavica Supplementum, 448.
12 Nilsson L, and Rybo G. 1967; The Treatment of Menorrhagia with an Anti-fibrinolytic Agent Tranexamic Acid (A.M.C.A.). Acta Obstetrica et Gynaecologica Scandinavica 46: 572.
13 O’Shea M. J, and Flute P. T. 1969; Husbandry of Blood Products; The Clinical Use of Cyclokapron. British Journal of Haematology 17: 612.
14 Prentice C. R. M, Lindsay R. M, Barr R. D, Forbes C. D, Kennedy A. C, McNicol G. P, and Douglas A. S. 1971; Renal Complications in Haemophilia and Christmas Disease. Quarterly Journal of Medicine New Series XL 157: 47.
15 Rainsford S. G, and Hall A. 1973; A Three Year Study of Adolescent Boys Suffering from Haemophilia and Allied Disorders. British Journal of Haematology 24: 533.
16 Reid W. O, Hodge S. M, and Cerutti E. R. 1967; The Use of E.A.C.A. in Preventing or Reducing Haemorrhages in the Haemophiliac. Thrombosis et Diathesis Haemorrhagica 18: 179.
17 Stark S. N, White J. G, Langer Jr. L, and Krivit W. 1965; Epsilon Amino-caproic Acid Therapy as a Cause of Intrarenal Obstruction in Haematuria of Haemophiliacs. Scandinavian Journal of Haematology 2: 99.
18 Strauss H. S, Kevy S. V, and Diamond L. K. 1965; Ineffectiveness of Prophylactic Epsilon Amino-caproic Acid in severe Haemophilia. New England Journal of Medicine 273: 301.
19 Tavenner R. W. H. 1972; Use of Tranexamic Acid in control of Haemorrhage after Extraction of Teeth in Haemophilia and Christmas Disease. British Medical Journal 2: 314.
20 van Itterbeek M, Vermylen J, and Verstraete M. 1968; High Obstruction of Urine Flow as a Complication of the Treatment with Fibrinolysis. Inhibitors of Haematuria in Haemophiliacs 39: 237.
21 Walsh P. N, Rizza C. R, Matthews J. M, Eipe J, Kernoff P. B. A, Coles M. D, Bloom A. L, Kaufman B. M, Beck P, Hanan C. M, and Biggs R. 1971; Epsilon Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease. British Journal of Haematology 20: 463.